All articles by Praveen Duddu

  1. Deals this week: Horama, Voyager Therapeutics, Fibrocell Science

    Horama SAS has raised €19m ($22m) in a series B funding round led by Fundplus, Pontifax Ltd, and IDInvest Partners….
    Read More…

    10 Nov
  2. M&As this week: Yifan Pharmaceutical, BioClinica

    Yifan Pharmaceutical plans to acquire Hong Kong-based pharmaceutical products distributor NovoTek Pharmaceuticals for CNY136m ($20.6m). The Chinese pharmaceutical company will complete…
    Read More…

    10 Nov
  3. Deals this week: Idera, Catalyst Biosciences, ADC Therapeutics

    Idera Pharmaceuticals Inc plans to raise $60m through an underwritten public offering of shares of its common stock. The US-based…
    Read More…

    27 Oct
  4. M&As this week: Bracket Global, Finch Therapeutics

    Bracket Global LLC has acquired mobile technology solutions provider mProve Health Inc. The acquisition enables the clinical trial technology and…
    Read More…

    27 Oct
  5. Deals this week: Myovant Sciences, Biogen, Telix Pharmaceuticals

    Myovant Sciences Ltd plans to raise $60m through the private placement of 15% notes bearing a maturity date of 16…
    Read More…

    20 Oct
  6. Deals this week: Ixaltis, Arbutus Biopharma, Gesynta Pharma

    French specialist pharmaceutical company Ixaltis has signed an agreement with Swiss biopharmaceutical company Xigen for worldwide rights to a compound being…
    Read More…

    6 Oct
  7. Deals this week: MediciNova, Confo Therapeutics, Intra-Cellular Therapies

    US-based biopharmaceutical company MediciNova plans to raise up to $200m by issuing securities on occasion. The company plans to issue one…
    Read More…

    29 Sep
  8. Report: Immuno-Oncology to evolve as promising cancer treatment alternative

    Immuno-oncology (IO) will be a crucial cancer treatment option alongside four other options, including surgery, radiotherapy, chemotherapy, and other targeted…
    Read More…

    14 Sep
  9. Deals this week: Sanofi, Entasis Therapeutics, Helsinn Therapeutics (US)

    Sanofi has entered a research agreement with drug discovery services provider Axxam. The partnership is aimed at optimising numerous small…
    Read More…

    7 Sep
  10. Report: Type 2 diabetes market to grow at CAGR of 8.4% up to 2026

    The type 2 diabetes market is expected to more than double from $26.8bn in 2016 to $64bn by 2026, according…
    Read More…

    17 Aug